Skip to main content

Table 1 LV functional analysis

From: Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis

  Control Day 14 Day 21
LVEF (%) 66 (6) 65 (8) 47 (16) †
LVM (mg) 345 (33) 348 (72) 545 (156) *
LVM/BW (mg/g) 1.46 (0.27) 2.22 (0.54) † 3.01 (0.99) †
LVEDV (μl) 361 (34) 245 (37) † 309 (22) †
LVEDV/BW (μl/g) 1.52 (0.24) 1.56 (0.22) 1.69 (0.15)
LVESV (μl) 121 (16) 86 (17) † 163 (55)
LVESV/BW (μl/g) 0.50 (0.02) 0.54 (0.13) 0.90 (0.33) †
BW (g) 239 (25) 158 (14) † 183 (15) †
  1. LV function was analyzed on cine CMR. Mean (SD) of LVEF, LVM, LVM/BW, LVEDV, LVEDV/BW, LVESV, LVESV/BW, and BW of the control, early phase (day 14), and peak phase (day 21) groups are shown. [BW = body weight. Statistical analysis; * p = 0.01, †p < 0.01 compared to the control.] LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVM, left ventricular mass